Quantcast

Latest Boehringer Ingelheim Stories

2014-06-12 08:28:27

Today most medicines are produced biotechnologically. A new cleaning method developed at ACIB combines five purification steps and leads to an extremely facilitated, more economical and ecological manufacturing process. GRAZ, Austria, June 12, 2014 /PRNewswire/ -- Seven of the ten best-selling drugs in 2012 were biopharmaceuticals; biotechnology in pharmaceutical production is still growing. A severe problem is the cleaning of products; up to 80% of the total production costs are...

2014-06-10 23:13:15

The Long Island, New York law firm of Rudolph F. X. Migliore, P. C. has announced the makers of the drug called Pradaxa have agreed to pay out 650 million to resolve most of the 4,000 cases filed in state and federal courts. (PRWEB) June 10, 2014 The New York Times states, “Pradaxa, which was approved in 2010, was the first in a new group of blood thinners intended to replace an older treatment, warfarin, which required patients to submit to frequent blood tests and adhere to a strict...

2014-06-05 23:01:35

A recent settlement announcement involving Pradaxa has been announced by the manufacture, Boehringer Ingelheim. Toledo, Ohio (PRWEB) June 05, 2014 Boehringer Ingelheim, the manufacturing company of the blood thinning drug Pradaxa, announced in May 2014 a $650 million settlement deal this week to settle approximately 4,000 state and federal lawsuits. Reported by TIME May 2014, Pradaxa was approved by the US Food and Drug Administration (FDA) in October 2010, Pradaxa is formulated for use...

2014-06-03 23:14:55

German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle thousands of claims against the drug manufacturer for injuries and deaths caused by the blood thinner Pradaxa. Columbus, Ohio (PRWEB) June 03, 2014 O’Connor, Acciani & Levy, an Ohio pharmaceutical litigation firm, continue to investigate claims regarding Pradaxa, a blood thinner manufactured by German pharmaceutical company Boehringer Ingelheim GmbH. According to a Bloomberg report published on May 28,...

2014-05-31 23:04:13

Greg Coleman Law reviews the impact of Boehringer’s settlement offer and the drugmaker’s motivations in light of the more than 4,000 pending Pradaxa lawsuits in U.S. courts. Knoxville, TN (PRWEB) May 31, 2014 Greg Coleman Law, a Tennessee defective drug litigation law firm, continues to express concerns about the proposed Pradaxa litigation settlement announced by Boehringer Ingelheim GmbH on May 28, 2014. The firm continues to review and investigate claims that the blood thinner...

2014-05-29 23:15:58

Boehringer Ingelheim Agrees to Pay $650 Million To Settle 4,000 Pradaxa Lawsuit That Allege Internal Bleeding After Taking The Prescription Medication. Columbus, OH (PRWEB) May 29, 2014 Wright & Schulte LLC, an experienced personal injury law firm representing plaintiffs in Pradaxa lawsuits pending in federal court, reports that Boehringer Ingelheim has agreed to pay $650 million to settle Pradaxa lawsuits filed on behalf of plaintiffs who allegedly experienced serious internal...

2014-05-29 16:26:15

Boehringer Ingelheim agrees to pay $650 Million to compensate the nearly 4,000 individuals who allege they were injured as a result of Pradaxa usage. CHICAGO, May 29, 2014 /PRNewswire/ -- TorHoerman Law is pleased to announce that the Pradaxa litigation that it has helped lead since before the Multi-District Litigation (MDL) was formed is set to be resolved by settlement. Boehringer Ingelheim, which manufactures the drug, and lead plaintiffs' counsel, including Tor Hoerman, reached...

2014-05-28 23:04:24

Roger C. Denton, Plaintiffs' Co-Lead Counsel and a lead negotiator in the Pradaxa® MDL, reports that a $650 Million settlement has been reached today with Boehringer Ingelheim Pharmaceuticals, Inc. (and affiliates) to settle approximately 4,000 Pradaxa® claims. St. Louis, MO (PRWEB) May 28, 2014 The Plaintiffs’ Steering Committee, appointed by The Honorable Chief Judge David R. Herndon to negotiate the settlement on behalf of all plaintiffs in the Pradaxa® MDL, and...

2014-05-28 23:01:48

Seth A. Katz and Burg Simpson Eldredge Hersh & Jardine, P.C. are pleased to announce that earlier today Boehringer Ingelheim Pharmaceuticals, Inc. and its related companies agreed to pay $650,000,000 to settle close to 4,000 claims brought on behalf of individuals who were injured after taking the company’s anticoagulant drug, Pradaxa (dabigatran etexilate). (PRWEB) May 28, 2014 Denver, Colorado: Seth A. Katz and Burg Simpson Eldredge Hersh & Jardine, P.C. are pleased to...

2014-05-28 08:31:29

RIDGEFIELD, Conn., May 28, 2014 /PRNewswire/ -- Boehringer Ingelheim (BI) announced today that it has reached a comprehensive settlement of state and federal cases in the U.S. litigation regarding Pradaxa® (dabigatran etexilate mesylate) in the amount of $650 million. "Time and again, the benefits and safety of PRADAXA have been confirmed," said Desiree Ralls-Morrison, senior vice president and general counsel, Boehringer Ingelheim USA Corporation. "BI stands resolutely behind PRADAXA and...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related